2 reports

  • 9.1.4 PHASE I

Molecular Pathology of Non-Small Cell Lung Cancer.

  • Lung Cancer
  • Pathology
  • Targeted Therapy
  • Therapy
  • ARIAD Pharmaceuticals, Inc.

For diagnosis of ALL, ##% or greater bone marrow lymphoblasts are required; similar pathology with the presence of lymphoblasts in other locations is classified as lymphoblastic lymphoma.

  • Pathology
  • Europe
  • Japan
  • United States
  • ARIAD Pharmaceuticals, Inc.